BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15924360)

  • 1. Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumors.
    Kieffer-Renaux V; Viguier D; Raquin MA; Laurent-Vannier A; Habrand JL; Dellatolas G; Kalifa C; Hartmann O; Grill J
    Pediatr Blood Cancer; 2005 Nov; 45(6):814-9. PubMed ID: 15924360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage.
    Grill J; Viguier D; Kieffer V; Bulteau C; Sainte-Rose C; Hartmann O; Kalifa C; Dellatolas G
    J Neurosurg; 2004 Nov; 101(2 Suppl):152-8. PubMed ID: 15835102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injuries to inferior vermis and dentate nuclei predict poor neurological and neuropsychological outcome in children with malignant posterior fossa tumors.
    Puget S; Boddaert N; Viguier D; Kieffer V; Bulteau C; Garnett M; Callu D; Sainte-Rose C; Kalifa C; Dellatolas G; Grill J
    Cancer; 2009 Mar; 115(6):1338-47. PubMed ID: 19195041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of hydrocephalus on intelligence quotient in children with localized infratentorial ependymoma before and after focal radiation therapy.
    Merchant TE; Lee H; Zhu J; Xiong X; Wheeler G; Phipps S; Boop FA; Sanford RA
    J Neurosurg; 2004 Nov; 101(2 Suppl):159-68. PubMed ID: 15835103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.
    Mulhern RK; Palmer SL; Merchant TE; Wallace D; Kocak M; Brouwers P; Krull K; Chintagumpala M; Stargatt R; Ashley DM; Tyc VL; Kun L; Boyett J; Gajjar A
    J Clin Oncol; 2005 Aug; 23(24):5511-9. PubMed ID: 16110011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98.
    Carrie C; Grill J; Figarella-Branger D; Bernier V; Padovani L; Habrand JL; Benhassel M; Mege M; Mahé M; Quetin P; Maire JP; Baron MH; Clavere P; Chapet S; Maingon P; Alapetite C; Claude L; Laprie A; Dussart S
    J Clin Oncol; 2009 Apr; 27(11):1879-83. PubMed ID: 19273707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.
    Krishnamoorthy P; Freeman C; Bernstein ML; Lawrence S; Rodd C
    Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in neurocognitive functioning after treatment with cranial radiation in childhood.
    Spiegler BJ; Bouffet E; Greenberg ML; Rutka JT; Mabbott DJ
    J Clin Oncol; 2004 Feb; 22(4):706-13. PubMed ID: 14966095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy.
    Jalali R; Mallick I; Dutta D; Goswami S; Gupta T; Munshi A; Deshpande D; Sarin R
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):974-9. PubMed ID: 19864079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure.
    Douglas JG; Barker JL; Ellenbogen RG; Geyer JR
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1161-4. PubMed ID: 15001259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three- and four-year cognitive outcome in children with noncortical brain tumors treated with whole-brain radiotherapy.
    Radcliffe J; Packer RJ; Atkins TE; Bunin GR; Schut L; Goldwein JW; Sutton LN
    Ann Neurol; 1992 Oct; 32(4):551-4. PubMed ID: 1456739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes.
    Grill J; Renaux VK; Bulteau C; Viguier D; Levy-Piebois C; Sainte-Rose C; Dellatolas G; Raquin MA; Jambaqué I; Kalifa C
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):137-45. PubMed ID: 10477017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood.
    Mabbott DJ; Spiegler BJ; Greenberg ML; Rutka JT; Hyder DJ; Bouffet E
    J Clin Oncol; 2005 Apr; 23(10):2256-63. PubMed ID: 15800316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychologic function in children with brain tumors: II. Serial studies of intellect and time after treatment.
    Kun LE; Mulhern RK
    Am J Clin Oncol; 1983 Dec; 6(6):651-6. PubMed ID: 6637877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.
    Ris MD; Packer R; Goldwein J; Jones-Wallace D; Boyett JM
    J Clin Oncol; 2001 Aug; 19(15):3470-6. PubMed ID: 11481352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive outcome of long-term survivors of multisystem langerhans cell histiocytosis: a single-institution, cross-sectional study.
    Nanduri VR; Lillywhite L; Chapman C; Parry L; Pritchard J; Vargha-Khadem F
    J Clin Oncol; 2003 Aug; 21(15):2961-7. PubMed ID: 12885816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: an analysis of the Head Start II survivors.
    Sands SA; Oberg JA; Gardner SL; Whiteley JA; Glade-Bender JL; Finlay JL
    Pediatr Blood Cancer; 2010 Mar; 54(3):429-36. PubMed ID: 20052775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
    Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
    Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling clinical outcome of children with autistic spectrum disorders.
    Coplan J; Jawad AF
    Pediatrics; 2005 Jul; 116(1):117-22. PubMed ID: 15995041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.